Source: ERJ Open Res, 8 (1) 00474-2021; 10.1183/23120541.00474-2021



Rating:

Share or cite this content

Citations should be made in the following way:
Takashi Nishida, Eriko Kawate, Takashi Ishiguro, Tetsu Kanauchi, Yoshihiko Shimizu, Noboru Takayanagi. Antigen avoidance and outcome of nonfibrotic and fibrotic hypersensitivity pneumonitis. ERJ Open Res, 8 (1) 00474-2021; 10.1183/23120541.00474-2021

Member's Comments

No comment yet.

Related content which might interest you: Diagnosis and management of chronic fibrotic hypersensitivity pneumonitis Source: Virtual Congress 2020 – Diagnosis and management of chronic fibrotic hypersensitivity pneumonitis Year: 2020 Distinguishing fibrotic hypersensitivity pneumonitis from idiopathic pulmonary fibrosis Source: International Congress 2019 – Lungs in the fog Year: 2019 Interstitial pneumonia vs. hypersensitivity pneumonitis with autoimmune features Source: International Congress 2017 – ILDs: clinical problems Year: 2017 Variable utility of mosaic attenuation to distinguish fibrotic hypersensitivity pneumonitis from idiopathic pulmonary fibrosis Source: Eur Respir J, 54 (1) 1900531; 10.1183/13993003.00531-2019 Year: 2019 Bronchial hyperresponse in hypersensitivity pneumonitis Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease Year: 2010 Chronic hypersensitivity pneumonitis and its differential diagnosis Source: ISSN=ISSN 1025-448x, ISBN=ISBN 978-1-904097-51-8, page=189 Year: 2007 Usual interstitial pneumonia pattern in chronic hypersensitivity pneumonitis Source: International Congress 2016 – Clinical aspects of ILD Year: 2016 Risk of hypersensitivity pneumonitis and interstitial lung diseases among pigeon breeders Source: Eur Respir J 2016; 48: 818-825 Year: 2016 Induced sputum in the follow-up of hypersensitivity pneumonitis Source: Eur Respir J 2001; 18: Suppl. 33, 114s Year: 2001 Factors predicting response to azathioprine in chronic hypersensitivity pneumonitis – the importance of BAL lymphocytosis Source: International Congress 2018 – Clinical aspects of hypersensitivity pneumonitis (HP) and CTD-ILD: diagnosis, monitoring and treatment Year: 2018 Cyclophosphamide in steroid-refractory hypersensitivity pneumonitis and non-classifiable interstitial lung disease Source: International Congress 2017 – Novel and old entities Year: 2017 Importance of unrecognised exposure to avian antigen in chronic bird-related hypersensitivity pneumonitis Source: Annual Congress 2009 - Clinical aspects of diffuse parenchymal lung disease Year: 2009 Pulmonary hypertension in hypersensitivity pneumonitis. Source: International Congress 2018 – Pulmonary hypertension in lung diseases and the role of the right ventricle Year: 2018 Hypersensitivity pneumonitis Source: Annual Congress 2004 - PG10 - Occupational and environmental disorders of the lung parenchyma Year: 2004 Hypersensitivity pneumonitis Source: ERS Course 2019 - Interstitial Lung Diseases Year: 2018 Hypersensitivity pneumonitis Source: ERS Course 2016 Year: 2016 Hypersensitivity pneumonitis Source: ERS Courses: Interstitial Lung Diseases Year: 2019 Hypersensitivity pneumonitis Source: ERS Course 2019 - Interstitial Lung Diseases Year: 2019 Hypersensitivity pneumonitis Source: School Course 2014 - Interstitial lung diseases Year: 2014